✦ LIBER ✦

The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 C3435T polymorphisms and gender on the urinary excretion of the metabolites of the H1-receptor antihistamine ebastine: a pilot study

✍ Scribed by Guillermo Gervasini; Sonia Vizcaino; Juan Antonio Carrillo; Maria Jesus Caballero; Julio Benitez

Book ID: 108641525
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 246 KB
Volume: 62
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2006.02578.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro study on the involvement of CYP

In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol

✍ L. Pan; F. M. Belpaire 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 138 KB

Effects of Daily Ingestion of Cranberry

Effects of Daily Ingestion of Cranberry Juice on the Pharmacokinetics of Warfarin, Tizanidine, and Midazolam—Probes of CYP2C9, CYP1A2, and CYP3A4

✍ Lilja, J J; Backman, J T; Neuvonen, P J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Influence of rabeprazole and lansoprazol

Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients

✍ Masatomo Miura; Kazuyuki Inoue; Hideaki Kagaya; Shigeru Satoh; Hitoshi Tada; Yos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Minimal effect of MDR1 and CYP3A5 geneti

Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients

✍ Caroline Solas; Nicolas Simon; Marie-Pierre Drogoul; Sylvie Quaranta; Véronique 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Effect of St John's wort on the activiti

Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females

✍ Markus Wenk; Liliane Todesco; Stephan Krähenbühl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Eltrombopag, an oral thrombopoietin rece

Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis

✍ Julian Jenkins; Daphne Williams; Yanli Deng; David A. Collins; Valerie S. Kitche 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 301 KB